NO20055173L - Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel - Google Patents

Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel

Info

Publication number
NO20055173L
NO20055173L NO20055173A NO20055173A NO20055173L NO 20055173 L NO20055173 L NO 20055173L NO 20055173 A NO20055173 A NO 20055173A NO 20055173 A NO20055173 A NO 20055173A NO 20055173 L NO20055173 L NO 20055173L
Authority
NO
Norway
Prior art keywords
combination
modafinil
another drug
pharmaceutical
pharmaceutical combination
Prior art date
Application number
NO20055173A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055173D0 (no
Inventor
Jeffrey L Vaught
Rodney J Hughes
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of NO20055173D0 publication Critical patent/NO20055173D0/no
Publication of NO20055173L publication Critical patent/NO20055173L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20055173A 2003-05-16 2005-11-03 Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel NO20055173L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47130203P 2003-05-16 2003-05-16
US10/845,836 US20040229943A1 (en) 2003-05-16 2004-05-14 Analeptic and drug combinations
PCT/US2004/015408 WO2004103359A1 (en) 2003-05-16 2004-05-17 Pharmaceutical combination comprising modafinil and another drug

Publications (2)

Publication Number Publication Date
NO20055173D0 NO20055173D0 (no) 2005-11-03
NO20055173L true NO20055173L (no) 2005-12-12

Family

ID=33424098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055173A NO20055173L (no) 2003-05-16 2005-11-03 Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel

Country Status (14)

Country Link
US (1) US20040229943A1 (enExample)
EP (1) EP1635807A1 (enExample)
JP (1) JP2007506801A (enExample)
KR (1) KR20060015727A (enExample)
AU (1) AU2004241110A1 (enExample)
BR (1) BRPI0411176A (enExample)
CA (1) CA2524870A1 (enExample)
EA (1) EA200501821A1 (enExample)
IS (1) IS8099A (enExample)
MX (1) MXPA05012358A (enExample)
MY (1) MY135829A (enExample)
NO (1) NO20055173L (enExample)
TW (1) TW200509896A (enExample)
WO (1) WO2004103359A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20030131B1 (en) * 2000-07-27 2011-03-31 Teva Pharmaceutical Industries Ltd. Crystalline and pure modafinil, and process of preparing the same
US20070053976A1 (en) * 2002-05-17 2007-03-08 Eisai R & D Management Co., Ltd. Novel combination of drugs as antidepressant
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
WO2005099822A2 (en) * 2004-04-13 2005-10-27 Cephalon, Inc. Reduction of drug / drug interactions with modafinil
EP1996291B1 (en) * 2006-03-23 2010-11-17 Yissum Research Development Company, of The Hebrew University of Jerusalem Use of digitalis-like compounds in the treatment of affective disorders
DE102006015734A1 (de) * 2006-04-04 2007-10-11 Hermann, Holger Lars, Dr. Kombinationspräparate aus Modafinil, Ritalin und Topiramat und deren Derivaten zur Behandlung von Kokainabhängigkeit und/oder Impulskontrollstörung
RU2435570C2 (ru) * 2006-12-01 2011-12-10 Нитто Денко Корпорейшн Композиция для чрескожного всасывания
US20080131490A1 (en) * 2006-12-01 2008-06-05 Akinori Hanatani Stabilized donepezil-containing patch preparation
WO2009145177A1 (ja) * 2008-05-30 2009-12-03 日東電工株式会社 ドネペジル含有貼付製剤およびその包装体
CA2725484A1 (en) * 2008-05-30 2009-12-03 Eisai R&D Management Co., Ltd. Percutaneously absorbable preparation
US20110224196A1 (en) * 2010-01-07 2011-09-15 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696153A (en) * 1994-05-16 1997-12-09 Napro Biotherapeutics, Inc. Therapeutic regimen for treating patients
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
WO2001013921A1 (en) * 1999-08-23 2001-03-01 Ockert David M Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations

Also Published As

Publication number Publication date
EA200501821A1 (ru) 2006-06-30
JP2007506801A (ja) 2007-03-22
TW200509896A (en) 2005-03-16
KR20060015727A (ko) 2006-02-20
MY135829A (en) 2008-07-31
CA2524870A1 (en) 2004-12-02
MXPA05012358A (es) 2006-02-02
BRPI0411176A (pt) 2006-07-18
WO2004103359A1 (en) 2004-12-02
AU2004241110A1 (en) 2004-12-02
EP1635807A1 (en) 2006-03-22
NO20055173D0 (no) 2005-11-03
IS8099A (is) 2005-10-27
US20040229943A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
HUE040046T2 (hu) Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
ITMI20041317A1 (it) Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
NO20071751L (no) Fremgangsmater og kit for levering av legemidler ved nebulisering
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
NO20053224D0 (no) Patient controlled drug administration device.
IS7076A (is) Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
DE602004000260D1 (de) Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
EA200401252A1 (ru) Микрочастицы лекарственных веществ
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
NO20092527L (no) Prolegemidler, fremgangsmate for fremstilling og anvendelse derav
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
DK1032376T3 (da) Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
DK1546127T3 (da) Nye pyrimidinamidderivater og anvendelse deraf
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
NO20055838L (no) Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
DK1696913T3 (da) Vinfluninholdigt farmaceutisk præparat til parenteral administration, fremgangsmåde til fremstilling deraf og dets anvendelse
NO20075508L (no) Stannsoporfinpreparater og administrering
NO20051159L (no) Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein